Search

everythinglearnresearchcommunity

for

Search:↓

TAGX-0003 protected hair follicles and reversed alopecia areata in a mouse model.

Estrogen alone can lower testosterone in some transfeminine people.

SARMs may be an effective treatment for a certain type of breast cancer by blocking cancer growth and spread.

New and future treatments for male hypogonadism include various forms of testosterone therapy and emerging drugs.

A 15-year-old girl with rare reproductive disorders received hormone therapy to develop secondary sexual traits, but infertility persisted.

Certain medications including flutamide, spironolactone, and others effectively reduce excessive hair growth in women, especially when combined with lifestyle changes.

Exposure to certain sex hormones can increase health risks, while some hormone therapies may offer benefits for specific conditions.

Antiandrogen drugs can reduce PSA levels in women with excess hair, suggesting PSA is a sign of male hormone activity in women.

Dutasteride is more effective for male pattern baldness than finasteride, and black cohosh extract BNO 1055 is as effective as conjugated estrogens in treating postmenopausal symptoms, with added benefits in reducing sweating and mental symptoms.

The document concludes that proper diagnosis and individualized treatment are crucial for managing androgenization in women effectively.

Removing the ovarian tumor improved the woman's hormonal symptoms.

Hormone therapy greatly improves the quality of life for adults seeking gender reaffirmation, but more research is needed in India.

Bicalutamide may reduce hair shedding in women but needs longer trials to confirm its effectiveness.

Blocking glucocorticoid receptors improves glucose metabolism in a PCOS mouse model.

Affected males are born with ambiguous genitalia, raised as females, but develop male traits at puberty due to enzyme deficiency.

For women with moderate to severe unwanted hair growth or acne, birth control pills are the first choice, with other medications like cyproterone, spironolactone, flutamide, or finasteride as alternatives, and permanent hair removal should be done with electrolysis or laser.

Progestogens are essential in menopausal hormone therapy to prevent uterine cancer and must be chosen carefully based on individual needs.

Androgens reduce macrophage receptor expression, affecting immune response, while antiandrogens counteract this effect.

Safflower oil nanoparticles can deliver hFGF10 to hair follicles, reduce inflammation, and potentially speed up hair growth in conditions causing hair loss.

New steroidal compounds could be effective for treating conditions related to 5α-reductase enzyme activity.

Nafarelin may effectively treat excessive hair growth in women by reducing certain hormone levels.

Spironolactone can reduce hair growth and testosterone in hirsutism, but is less effective than combined treatments.

Genetic profiling can improve androgenetic alopecia treatment by predicting drug response and minimizing side effects.

Blocking the Hedgehog pathway may help overcome drug resistance in multiple myeloma.

Finasteride effectively inhibits the enzyme steroid 5 alpha-reductase II.

New A-homo-B, 19-dinor steroids showed strong antiandrogenic activity without affecting the enzyme 5α-reductase or androgen receptor binding.

The drug TGU was ineffective against small cell lung cancer and caused significant bone marrow suppression.

GnRH-a or orchiectomy is more effective than anti-androgens for managing hormone levels in transgender women.

Tetrahydroxystilbene Glucoside may help prevent hair loss by blocking certain pathways that lead to cell death.